These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12473803)
1. The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Barnabas RV; Carabin H; Garnett GP Sex Transm Infect; 2002 Dec; 78(6):425-9. PubMed ID: 12473803 [TBL] [Abstract][Full Text] [Related]
2. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis. Randolph AG; Hartshorn RM; Washington AE Obstet Gynecol; 1996 Oct; 88(4 Pt 1):603-10. PubMed ID: 8841227 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Baker D; Brown Z; Hollier LM; Wendel GD; Hulme L; Griffiths DA; Mauskopf J Am J Obstet Gynecol; 2004 Dec; 191(6):2074-84. PubMed ID: 15592294 [TBL] [Abstract][Full Text] [Related]
5. Debate: the argument for. Should all pregnant women be offered type-specific serological screening for HSV infection? Kinghorn GR Herpes; 2002 Jul; 9(2):46-7. PubMed ID: 12106511 [TBL] [Abstract][Full Text] [Related]
6. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial. Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557 [TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa. Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy. Scott LL; Alexander J Am J Perinatol; 1998 Jan; 15(1):57-62. PubMed ID: 9475690 [TBL] [Abstract][Full Text] [Related]
10. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis. Little SE; Caughey AB Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1274-9. PubMed ID: 16157151 [TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of neonatal herpes simplex virus infection. Samies NL; James SH Antiviral Res; 2020 Apr; 176():104721. PubMed ID: 32044154 [TBL] [Abstract][Full Text] [Related]
12. Antenatal herpes serologic screening: an appraisal of the evidence. Tita AT; Grobman WA; Rouse DJ Obstet Gynecol; 2006 Nov; 108(5):1247-53. PubMed ID: 17077252 [TBL] [Abstract][Full Text] [Related]
13. Acyclovir in pregnancy for primary prevention of neonatal herpes. Stiffman MN; Adam P J Fam Pract; 1997 Jan; 44(1):29-30. PubMed ID: 9010365 [No Abstract] [Full Text] [Related]
17. Prevention, recognition and management of neonatal HSV infections. Robinson JL; Vaudry WL; Forgie SE; Lee BE Expert Rev Anti Infect Ther; 2012 Jun; 10(6):675-85. PubMed ID: 22734957 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus infection during pregnancy. Stephenson-Famy A; Gardella C Obstet Gynecol Clin North Am; 2014 Dec; 41(4):601-14. PubMed ID: 25454993 [TBL] [Abstract][Full Text] [Related]
19. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068 [TBL] [Abstract][Full Text] [Related]
20. Debate: the argument against. Should all pregnant women be offered type-specific serological screening for HSV infection? Arvin AM Herpes; 2002 Jul; 9(2):48-50. PubMed ID: 12106512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]